Community respiratory virus infections following lung transplantation

Transplant Infectious Disease

Volumn 3, Issue 3, 2001, Pages 138-148

  Billings, J L ^a   Hertz, M I ^a   Wendt, C H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adenovirus; Influenza virus; Lung transplantation; Parainfluenza virus (PIV); Respiratory syncytial virus (RSV)

Indexed keywords

IMMUNOGLOBULIN G; RIBAVIRIN;

ADENOVIRUS; CLINICAL FEATURE; CYTOMEGALOVIRUS; HUMAN; INFLUENZA VIRUS; LUNG TRANSPLANTATION; MORBIDITY; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADENOVIRIDAE INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; PARAMYXOVIRIDAE INFECTIONS; POSTOPERATIVE COMPLICATIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 0034877010     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2001.003003138.x     Document Type: Review

References (71)

1. Paramyxovirus infection in lung transplant recipients
2. Respiratory syncytial virus pneumonia in a lung transplant recipient: Case report
3. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants
4. Dual infection with Pneumocystis carinii and respiratory viruses complicating bone marrow transplantation
5. Respiratory syncytial virus-induced lung injury in adult patients with bone marrow transplants: A clinical approach and review of the literature
6. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host
7. Parainfluenza virus respiratory infection after bone marrow transplantation
8. Parainfluenza virus infection in adult bone marrow transplant recipients
9. Respiratory virus infection in immunocompromised patients
10. Respiratory syncytial virus
11. Respiratory syncytial and parainfluenza viruses
12. Respiratory syncytial virus infection in the elderly 1976-82
13. Respiratory syncytial virus infection in immunocompromised adults
14. Respiratory syncytial virus pneumonitis-induced diffuse alveolar damage in an autologous bone marrow transplant recipient
15. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults
16. An outbreak of respiratory syncytial virus in a bone marrow transplant center
17. Respiratory syncytial viral infection in children with compromised immune function
18. Immunity to and frequency of reinfection with respiratory syncytial virus
19. Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses
20. Culture vs. direct antigen assays for detection of microbial pathogens from lower respiratory tract specimen suspected of containing the respiratory syncytial virus
21. Detection, pathogenesis and therapy of respiratory syncytial virus infections
22. Laboratory diagnosis of respiratory virus infections in 24 hours by utilizing shell vial cultures
23. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV
24. Ribavirin for respiratory syncytial virus lower respiratory tract infection
25. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
26. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
27. Parainfluenza viruses
28. Parainfluenza viruses
29. Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease
30. Clinical characteristics of parainfluenza virus infection in hospitalized children
31. Viral pneumonia in the immunocompromised adult with neoplastic disease: The role of common community respiratory viruses
32. Parainfluenza virus infection in adult bone marrow transplant recipients
33. Respiratory virus infection in immunocompromised patients
34. Parainfluenza Type 3 in a transplant unit
35. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation
36. Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection
37. Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: Use of reverse transcription-PCR-enzyme immunoassay
38. Influenza virus
39. Influenza
40. Influenza
41. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults
42. Influenza B virus infection in pediatric solid organ transplant recipients
43. First International Symposium on Influenza and Other Respiratory Viruses: Summary and overview
44. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus
45. Influenza vaccination in heart transplant recipients
46. Prophylaxis and treatment of influenza
47. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infection
48. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
49. Zanamivir in the prevention of influenza among healthy adults a randomized controlled trial
50. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
51. Adenovirus in the immunocompromised host
52. Adenovirus
53. Adenovirus infection in pediatric liver transplant recipients
54. Adenovirus pneumonia in lung transplant recipients
55. Adenovirus infections in immunocompromised patients
56. Adenovirus infections in hematopoietic stem cell transplant recipients
57. Late fatal adenovirus pneumonitis in a lung transplant recipient
58. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient
59. Intravenous ribavirin therapy for adenovirus pneumonia
60. Association of renal allograft rejection with virus infections
61. Viral infection and renal transplant rejection
62. Virus infections and acute renal transplant rejection
63. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis
64. Results of single and bilateral lung transplantation 131 consecutive recipients
65. Risk factors for the development of obliterative bronchiolitis after lung transplantation
66. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
67. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients
68. Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts
69. Guideline for isolation precautions in hospitals
70. Guideline for the prevention of nosocomial pneumonia. Parts I and II
71. Infection control of nosocomial respiratory viral disease in the immunocompromised host